Aspetar to host sports medicine forum until Qatar 2022

Aspetar, a sports medicine and orthopedic hospital, has announced a series of virtual forums based on the book “Aspetar sports medicine collection”, which will be organised from December until the Qatar 2022 World Cup starts.

The virtual forums will present healthcare professionals with the opportunity to interact and recognise the most important research, as well as many other topics on sports medicine that has made Aspetar an exemplary model in the world of sports medicine.

The “Aspetar Sports Medicine Collection” forum gives free access to information based on scientific evidence produced by the Aspetar scientific journal.

Running for two years

With the monthly celebration of the forum, starting from December 2020 until the start of the 2022 World Cup. Experts will discuss the 24 chapters of the book in just one month. The “Aspetar sports medicine collection” book was released in September.

The subject “Foot and ankle” will be the first to be addressed in detail in the first series of forums that begin on December 2, which will be led by Professor Piter Dokh, representative of Aspetar.

Several important topics of medicine and sports science will be addressed, including Hydration and Nutrition, Recovery Strategies, Sleep Problems and Long Trips, Sports Psychology, Heart Health, Pathology in Athletes, Ethics in Sports Medicine and Concussion in Sports.

Online forums

The forums will be held on Microsoft Teams, which allows for visual and auditory communication between participants. Registration for the virtual forums can be done online, through the Aspetar site. Participants will also be able tojoin in on the Twitter hashtag to ask any questions that will be answered during the sessions.

It is also worth mentioning that Aspetar aims to present reliable, evidence-based information to a considerable numbers of readers interested in the sports and medical fields, as well as to help build awareness and knowledge locally, regionally or internationally. Aspetar’s vision is to be the universal pioneer in the fields of sports medicine, orthopedics, and rehabilitation, thanks to its elaborate world-class facilities, modern technologies and research.

Source Article

Read more

HEXO Corp to Release Fourth Quarter and Fiscal Year 2020 Financial Results and Host Investor Webcast

OTTAWA, Oct. 27, 2020 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) plans to release its complete financial results for the quarter and fiscal year ended July 31, 2020, after market hours on Thursday, October 29, 2020, as well as host a webcast for investors and analysts beginning at 8:30 a.m. EDT on Friday October 30, 2020.

Webcast Details
Date: October 30, 2020
Time: 8:30 a.m. EDT
Webcast:  https://event.on24.com/wcc/r/2771524/47E7001045651D265D3F12D203F6F5A4

For previous quarterly results and recent press releases, see hexocorp.com.

About HEXO

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.

Forward Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Investor Relations:
[email protected]
www.hexocorp.com 

Media Relations:
(819) 317-0526
[email protected] 

Source Article

Read more